To further investigate the association of SIRT2 expression and NAFLD progression in clinical NAFLD patients, we assessed the levels of SIRT2 between healthy and NAFLD human subjects using two public microarray datasets, GSE164760 and GSE180882, from the Gene Expression Omnibus (GEO) database. This evidence concerns the gene SIRT2 and metabolic dysfunction-associated steatotic liver disease.